Document is current
Any future updates will be listed below
-
Authors
Westermann, Lena Marie
Baranowsky, Anke
Di Lorenzo, Giorgia
Danyukova, Tatyana
Soul, Jamie
Schwartz, Jean-Marc
Hendrickx, Gretl
Amling, Michael
Rose-John, Stefan
Garbers, Christoph
Schinke, Thorsten
Pohl, Sandra
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB877 (Projects A1, A10, A14 and B3), PO 1539/1-1)
European Community’s Seventh Framework Programme (n°602300 (SYBIL))
International Advocate for Glycoprotein Storage Diseases
National MPS Society
Australian MPS Society
Wagner Foundation
Spanish MPS Society
Irish MPS Society
Projekt DEAL
- License Information
-
More Information
Article History
Received: 25 September 2020
Accepted: 25 January 2021
First Online: 11 February 2021
Competing interests
: S.R.J. is an inventor on patents describing the function of sgp130Fc. He is also a shareholder of the CONARIS Research Institute (Kiel, Germany), which is commercially developing sgp130Fc proteins as therapeutics for inflammatory diseases. All other authors declare no competing financial interests.
